| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |